PMC Links for Gene (Select 2064) - PMC

Result Filters

Links from Gene

Items: 1 to 20 of 1354

<< First< Prev

Page of 68

Select item 111657611.

Mechanism of ERBB2 gene overexpression by the formation of super-enhancer with genomic structural abnormalities in lung adenocarcinoma without clinically actionable genetic alterations

Syuzo Kaneko, Ken Takasawa, Ken Asada, Kouya Shiraishi, Noriko Ikawa, Hidenori Machino, Norio Shinkai, Maiko Matsuda, Mari Masuda, Shungo Adachi, Satoshi Takahashi, Kazuma Kobayashi, Nobuji Kouno, Amina Bolatkan, Masaaki Komatsu, Masayoshi Yamada, Mototaka Miyake, Hirokazu Watanabe, Akiko Tateishi, Takaaki Mizuno, Yu Okubo, Masami Mukai, Tatsuya Yoshida, Yukihiro Yoshida, Hidehito Horinouchi, Shun-Ichi Watanabe, Yuichiro Ohe, Yasushi Yatabe, Vassiliki Saloura, Takashi Kohno, Ryuji Hamamoto

Mol Cancer. 2024; 23: 126. Published online 2024 Jun 11. doi: 10.1186/s12943-024-02035-6

PMCID:: PMC11165761

Abstract Article PDF–2.7M

Select item 111598692.

Induction of ErbB2 by ultraviolet A irradiation: Potential role in malignant transformation of keratinocytes

Chang Yeob Han, Sung Chul Lim, Hong Seok Choi, Keon Wook Kang

Cancer Sci. 2008 Mar; 99(3): 502–509. Published online 2008 Jan 2. doi: 10.1111/j.1349-7006.2007.00718.x

PMCID:: PMC11159869

Abstract Article PDF–259K

Select item 111593493.

HER2 overexpression correlates with survival after curative resection of pancreatic cancer

Masahiro Komoto, Bunzo Nakata, Ryosuke Amano, Nobuya Yamada, Masakazu Yashiro, Masaichi Ohira, Kenichi Wakasa, Kosei Hirakawa

Cancer Sci. 2009 Jul; 100(7): 1243–1247. Published online 2009 Mar 30. doi: 10.1111/j.1349-7006.2009.01176.x

PMCID:: PMC11159349

Abstract Article PDF–877K

Select item 109977624.

Human epidermal growth factor receptor-2 expression and subsequent dynamic changes in patients with ovarian cancer

Yoo-Na Kim, Yun Soo Chung, Eunhyang Park, Seung Tae Lee, Jung-Yun Lee

Sci Rep. 2024; 14: 7992. Published online 2024 Apr 5. doi: 10.1038/s41598-024-57515-y

PMCID:: PMC10997762

Abstract Article PDF–2.2M

Select item 109872955.

Site-specific glycosylation analysis of epidermal growth factor receptor 2 (ErbB2): exploring structure and function toward therapeutic targeting

Naoki Fujitani, Yasuaki Uehara, Shigeru Ariki, Ukichiro Hashimoto, Jo Mukai, Yoshihiro Hasegawa, Motoko Takahashi

Glycobiology. 2024 Mar; 34(3): cwad100. Published online 2023 Dec 18. doi: 10.1093/glycob/cwad100

Correction in:: Glycobiology. 2024 May; 34(5): cwae018.

PMCID:: PMC10987295

Abstract Article PDF–3.5M

Select item 108609466.

HER2-positive is an independent indicator for predicting pathological complete response to neoadjuvant therapy and Ki67-changed after neoadjuvant chemotherapy predicts favorable prognosis in Chinese women with locally advanced breast cancer

Yutong Fang, Qunchen Zhang, Yuan Wu, Jundong Wu

Medicine (Baltimore) 2024 Feb 9; 103(6): e37170. Published online 2024 Feb 9. doi: 10.1097/MD.0000000000037170

PMCID:: PMC10860946

Abstract Article PDF–1.7M

Select item 106045477.

Outcomes of advanced gastroesophageal cancer patients with equivocal HER2 expression with or without ERBB2 gene amplification

Ahmed Abdelhakeem, Xuemei Wang, Jane E. Rogers, Allison Trail, Meina Zhao, Mariela Blum-Murphy, J. S. Estrella, Jaffer A. Ajani

Oncology. Author manuscript; available in PMC 2023 Oct 27.

Published in final edited form as: Oncology. 2020; 98(12): 884–888. Published online 2020 Sep 30. doi: 10.1159/000509148

PMCID:: PMC10604547

Abstract Article PDF–262K

Select item 105055938.

Is HER2 ultra-low breast cancer different from HER2 null or HER2 low breast cancer? A study of 1363 patients

Zhaoxu Chen, Huiqing Jia, Huina Zhang, Lifang Chen, Peng Zhao, Jing Zhao, Guangming Fu, Xiaoming Xing, Yujun Li, Chengqin Wang

Breast Cancer Res Treat. 2023; 202(2): 313–323. Published online 2023 Aug 28. doi: 10.1007/s10549-023-07079-8

PMCID:: PMC10505593

Abstract Article PDF–835K

Select item 102980709.

Upregulated Expression of ERBB2/HER2 in Multiple Myeloma as a Predictor of Poor Survival Outcomes

Fatih M. Uckun, Sanjive Qazi

Int J Mol Sci. 2023 Jun; 24(12): 9943. Published online 2023 Jun 9. doi: 10.3390/ijms24129943

PMCID:: PMC10298070

Abstract Article PDF–3.2M

Select item 1017946210.

HER2 Low Breast Cancer: A New Subtype or a Trojan for Cytotoxic Drug Delivery?

Marina Popović, Tajana Silovski, Marija Križić, Natalija Dedić Plavetić

Int J Mol Sci. 2023 May; 24(9): 8206. Published online 2023 May 4. doi: 10.3390/ijms24098206

PMCID:: PMC10179462

Abstract Article PDF–668K

Select item 1010179111.

Real World Characteristics and Clinical Outcomes of HER2-Mutant Non–Small Cell Lung Cancer Patients Detected by Next-Generation Sequencing

Beung-Chul Ahn, Ye-Jeong Han, Hye Ryun Kim, Min Hee Hong, Byoung Chul Cho, Sun Min Lim

Cancer Res Treat. 2023 Apr; 55(2): 488–497. Published online 2022 Nov 9. doi: 10.4143/crt.2022.359

PMCID:: PMC10101791

Abstract Article PDF–1.2M

Select item 1002412212.

Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer—results from an international, multicenter analysis coordinated by the AGMT Study Group

S.P. Gampenrieder, V. Dezentjé, M. Lambertini, A. de Nonneville, M. Marhold, F. Le Du, A. Cortés Salgado, D. Alpuim Costa, M. Vaz Batista, N. Chic Ruché, C. Tinchon, A. Petzer, E. Blondeaux, L. Del Mastro, G. Targato, F. Bertucci, A. Gonçalves, F. Viret, R. Bartsch, C. Mannsbart, A. Deleuze, L. Robert, C. Saavedra Serrano, M. Gion Cortés, M. Sampaio-Alves, M. Vitorino, L. Pecen, C. Singer, N. Harbeck, G. Rinnerthaler, R. Greil, AGMT Study Group

ESMO Open. 2023 Feb; 8(1): 100747. Published online 2022 Dec 21. doi: 10.1016/j.esmoop.2022.100747

PMCID:: PMC10024122

Abstract Article PDF–459K

Select item 999008013.

Histopathologic features and molecular genetic landscape of HER2-amplified endometrial carcinomas

Dara S. Ross, Kelly A. Devereaux, Cao Jin, David YunTe Lin, Yanming Zhang, Antonio Marra, Vicky Makker, Britta Weigelt, Lora H. Ellenson, M. Herman Chui

Mod Pathol. Author manuscript; available in PMC 2023 Mar 7.

Published in final edited form as: Mod Pathol. 2022 Jul; 35(7): 962–971. Published online 2021 Dec 31. doi: 10.1038/s41379-021-00997-2

PMCID:: PMC9990080

Abstract Article PDF–2.4M

Select item 996268814.

HER2 Expression in Bladder Cancer: A Focused View on Its Diagnostic, Prognostic, and Predictive Role

Francesca Sanguedolce, Magda Zanelli, Andrea Palicelli, Alessandra Bisagni, Maurizio Zizzo, Stefano Ascani, Maria Carmela Pedicillo, Angelo Cormio, Ugo Giovanni Falagario, Giuseppe Carrieri, Luigi Cormio

Int J Mol Sci. 2023 Feb; 24(4): 3720. Published online 2023 Feb 13. doi: 10.3390/ijms24043720

PMCID:: PMC9962688

Abstract Article PDF–1.2M

Select item 987553315.

Radiogenomic analysis of prediction HER2 status in breast cancer by linking ultrasound radiomic feature module with biological functions

Hao Cui, Yue Sun, Dantong Zhao, Xudong Zhang, Hanqing Kong, Nana Hu, Panting Wang, Xiaoxuan Zuo, Wei Fan, Yuan Yao, Baiyang Fu, Jiawei Tian, Meixin Wu, Yue Gao, Shangwei Ning, Lei Zhang

J Transl Med. 2023; 21: 44. Published online 2023 Jan 24. doi: 10.1186/s12967-022-03840-7

PMCID:: PMC9875533

Abstract Article PDF–10M

Select item 979799916.

Characteristics of the immunogenicity and tumor immune microenvironment in HER2-amplified lung adenocarcinoma

Qinyang Wang, Ziyang Mao, Wenyuan Li, Shumei Wang, Lei Wang, Lin Chen, Zhe Yang, Xiaolan Fu, Panpan Jiang, Yixue Bai, Longwen Xu, Shirong Zhang, Yuzhu Hou, Xiaohui Jia, Lili Jiang, Mengjie Liu, Guanjun Zhang, Yina Jiang, Hui Guo

Front Immunol. 2022; 13: 1042072. Published online 2022 Dec 15. doi: 10.3389/fimmu.2022.1042072

PMCID:: PMC9797999

Abstract Article PDF–8.7M

Select item 971579817.

ERBB2 exon 20 insertions are rare in Brazilian non‐small cell lung cancer

Rodrigo de Oliveira Cavagna, Beatriz Garbe Zaniolo, Flávia Escremim de Paula, Gustavo Noriz Berardinelli, Iara Santana, Eduardo Caetano Albino da Silva, Josiane Mourão Dias, Alexandre Arthur Jacinto, Rachid Eduardo Noleto da Nóbrega Oliveira, Pedro de Marchi, Letícia Ferro Leal, Rui Manuel Reis

Thorac Cancer. 2022 Dec; 13(23): 3402–3407. Published online 2022 Oct 17. doi: 10.1111/1759-7714.14605

PMCID:: PMC9715798

Abstract Article PDF–812K

Select item 947877618.

Comparison of Management and Outcomes in ERBB2-Low vs ERBB2-Zero Metastatic Breast Cancer in France

Ombline de Calbiac, Amélie Lusque, Audrey Mailliez, Thomas Bachelot, Lionel Uwer, Marie-Ange Mouret-Reynier, George Emile, Christelle Jouannaud, Anthony Gonçalves, Anne Patsouris, Véronique Diéras, Marianne Leheurteur, Thierry Petit, Paul Cottu, Jean-Marc Ferrero, Véronique D'Hondt, Isabelle Desmoulins, Joana Mourato-Ribeiro, Anne-Laure Martin, Jean-Sébastien Frenel

JAMA Netw Open. 2022 Sep; 5(9): e2231170. Published online 2022 Sep 15. doi: 10.1001/jamanetworkopen.2022.31170